Under normal circumstances, P-glycoprotein helps prevent potentially harmful substances from accumulating in the brain by transporting them out of sensitive tissues. Dogs with the MDR-1 mutation have reduced or absent transporter function, allowing certain drugs to reach toxic levels within the body. As a result, medications that are considered safe for most dogs can cause serious adverse reactions in affected individuals.
The severity of drug sensitivity depends on the dog's genetic status and the medication involved. Dogs with the MDR-1 mutation may experience symptoms such as excessive drooling, vomiting, diarrhea, weakness, lethargy, loss of coordination, tremors, disorientation, vision problems, seizures, difficulty breathing, coma, or even death in severe cases. Because affected dogs often appear completely healthy until exposed to a problematic medication, genetic testing is the most reliable method for identifying dogs at risk.
The MDR-1 DNA Health Test is designed to detect the specific mutation in the MDR1 gene. Testing is simple, safe, and non-invasive, typically requiring a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine the dog's genetic status. Since DNA remains unchanged throughout life, the test can be performed at any age, including in puppies before they receive medications that could pose a risk.
Results are generally reported in one of three categories:
- Clear (Normal): The dog has two normal copies of the MDR1 gene and is not expected to have increased sensitivity to MDR1-related medications.
- Carrier: The dog carries one normal copy and one mutated copy of the gene. Carriers may have mild to moderate drug sensitivity and can pass the mutation to their offspring.
- Affected: The dog carries two copies of the mutated gene and has a significantly increased risk of severe adverse reactions to certain medications.
The MDR-1 mutation is commonly found in several herding and working breeds, although it can occur in many breeds and mixed-breed dogs. Genetic testing provides critical information for veterinarians when selecting medications, determining dosages, and developing treatment plans. Knowing a dog's MDR-1 status can help prevent potentially life-threatening drug reactions and support safer veterinary care.
For breeders, MDR-1 testing is an essential part of responsible breeding programs. By identifying carriers and affected dogs, breeders can make informed mating decisions that reduce the prevalence of the mutation while preserving desirable breed traits and genetic diversity.
The Multi Drug Resistance (MDR-1) Health Test is a reliable genetic screening tool that helps identify dogs at risk for medication sensitivity. Early testing enables veterinarians and owners to make informed healthcare decisions, avoid potentially harmful medications, and provide personalized medical care. Through responsible breeding and proactive health management, the impact of MDR-1 can be significantly reduced in future generations of dogs.
